Healthcare


 MyHealthChecked (M3HC) & Alliance (APH): Are these pharma stocks a buy now?

MyHealthChecked (M3HC) & Alliance (APH): Are these pharma stocks a buy now?

September 30, 2021 04:55 PM AEST| By Nidhi Gupta

Highlights  MyHealthChecked had recently acquired Nell Health Ltd, a technology-led genetic-testing platform and provider of personalised nutrition solutions, for £1.2 million. Alliance Pharma declared an interim dividend of 0.563 pe.....

 AstraZeneca (LON: AZN) to acquire Caelum Biosciences: Buy alert?

AstraZeneca (LON: AZN) to acquire Caelum Biosciences: Buy alert?

September 30, 2021 01:24 AM AEST| By Suhita Poddar

Highlights Anglo-Swedish pharma company, AstraZeneca’s Alexion is set to acquire the remaining stake in rare disease biotech firm Caelum Biosciences. The deal is worth up to US$ 150 million, with a potential facility for making additional.....

 Sareum (SAR) returns 700% in a year: Is this small-cap share still a good buy?

Sareum (SAR) returns 700% in a year: Is this small-cap share still a good buy?

September 14, 2021 12:35 AM AEST| By Nidhi Gupta

HIGHLIGHTS Saerum raised £2.37 million in June 2021 through two subscription contracts with high-net-worth individuals. In July 2021, the company received approval from the US Patent and Trademark Office for the use of SDC-1802 drug molec.....

 Synairgen & Omega Diagnostics: 2 AIM pharma stocks for a healthy portfolio

Synairgen & Omega Diagnostics: 2 AIM pharma stocks for a healthy portfolio

September 09, 2021 05:34 PM AEST| By Nidhi Gupta

Highlights  Omega Diagnostics filed for CE-mark on Covid-19 antigen self-test ‘Visitect’. Synairgen, last year generated £87.1 million to fund the SG018 Phase III trial. The exceptional pace of technological advancem.....

 Open Orphan (ORPH) & Angle (AGL): 2 AIM pharma stocks to buy in September

Open Orphan (ORPH) & Angle (AGL): 2 AIM pharma stocks to buy in September

September 06, 2021 10:21 PM AEST| By Nidhi Gupta

Pharma stocks listed on AIM present attractive investment opportunities for investors seeking to diversify their portfolios, and they simultaneously offer ample growth prospects. AIM pharma stocks comprise smaller pharmaceutical companies that desi.....

 UK may offer Covid-19 jabs to 12- 15-year-olds. Stocks to look at

UK may offer Covid-19 jabs to 12- 15-year-olds. Stocks to look at

September 01, 2021 06:24 PM AEST| By Suhita Poddar

Highlights  NHS England to prepare for a potential extension of the Covid vaccination programme to all 12 to 15-year-olds from early September. No advice regarding vaccine rollout provided by JCVI yet, but forward planning to be started. .....

 Faron (LON: FARN) & Novacyt (LON: NCYT) shares. Should you buy them now?

Faron (LON: FARN) & Novacyt (LON: NCYT) shares. Should you buy them now?

August 26, 2021 10:28 PM AEST| By Kamalika Ghosh

Highlights  Faron Pharmaceuticals Oy share prices suffered a sharp correction of around 7 per cent. For the H1 2021 ended 30 June 2021, Novacyt recorded revenues of £94.7 million, up by over 50% compared to £63.3 million in H1 .....

 Inspira supports Vectura’s (LON: VEC) £1.1bn acquisition by Philip Morris

Inspira supports Vectura’s (LON: VEC) £1.1bn acquisition by Philip Morris

August 23, 2021 07:36 PM AEST| By Kamalika Ghosh

Highlights  Inspira Pharmaceuticals comes out to support Vecutra’s £1.1 billion takeover by US-based Philip Morris International amid rising criticism due to potential threats to the UN’s sustainability goals and future co.....

 UK’s Psychedelic sector and potential investment opportunities

UK’s Psychedelic sector and potential investment opportunities

August 19, 2021 05:46 PM AEST| By Kamalika Ghosh

Highlights Decades of research has shown Psychedelic substance such as LSD and Psilocybin can treat the mental disorder more efficiently than conventional therapies. The market size of the Psychedelic treatment was at USD five billion in 2020 a.....

 Is it the right time to invest in these 5 FTSE listed cannabis stocks?

Is it the right time to invest in these 5 FTSE listed cannabis stocks?

August 17, 2021 06:03 PM AEST| By Kamalika Ghosh

Very recently, in 2018 the UK legalised the medicinal use of cannabis. Medical cannabis, which is used to treat the pain and specific illnesses was first legalised in the United states for the treatment of Alzheimer's disease and other medical cond.....

 Pfizer booster shot - Which other vaccines may require booster doses?

Pfizer booster shot - Which other vaccines may require booster doses?

August 10, 2021 09:38 PM AEST| By Suhita Poddar

Summary  According to BioNTech, a booster shot of the two-shot Pfizer vaccine is expected to serve as a better strategy to fight new variant than altering the existing vaccine product. AstraZeneca is yet not sure if a booster dose of the C.....

 Pfizer and Flynn in the dock for overcharging NHS for anti-epilepsy drugs

Pfizer and Flynn in the dock for overcharging NHS for anti-epilepsy drugs

August 06, 2021 12:43 AM AEST| By Suhita Poddar

Summary  The Competition and Markets Authority has accused pharma major Pfizer and Flynn of overcharging for the anti-epileptic drug. Both Pfizer and Flynn exploited a loophole so that they would not face price regulation. The UK's Co.....

 Why have Pfizer and Moderna raised prices for vaccines in the EU?

Why have Pfizer and Moderna raised prices for vaccines in the EU?

August 02, 2021 09:05 PM AEST| By Kamalika Ghosh

Summary US-based COVID-19 vaccine manufacturers Pfizer and Moderna increased prices of their vaccines in the latest European Union supply contracts. The terms of the deal for 2.1 billion vaccine doses until 2023 were renegotiated, as the phase .....

 5 top FTSE healthcare stocks below £1

5 top FTSE healthcare stocks below £1

July 28, 2021 08:18 PM AEST| By Kamalika Ghosh

Summary  Investors often chose to invest in low-priced stocks in the healthcare sector, as few of such firms will emerge as big gainers in the long term. Events such as successful research attempts or a new drug launch are expected to boos.....

 AstraZeneca’s (LON: AZN) shares and the latest buzz around

AstraZeneca’s (LON: AZN) shares and the latest buzz around

July 20, 2021 08:47 PM AEST| By Suhita Poddar

AstraZeneca (LON: AZN), the pharmaceutical major,  which has been news for last some time due to its Covid-19 vaccine, is once again creating buzz after receiving approval in China for its small cell lung cancer drug Imfinzi.  Shares of t.....

 Lens on 5 AIM listed pharma stocks as CMA slaps £260-million fine on drug makers

Lens on 5 AIM listed pharma stocks as CMA slaps £260-million fine on drug makers

July 16, 2021 04:05 PM AEST| By Kamalika Ghosh

Summary  CMA slapped fines of over £260 million on drug makers after investigations revealed NHS was overcharged close to a decade for hydrocortisone tablets. Prices of hydrocortisone increased by over 10,000 per cent over the years......

 Which are the 10 biggest FTSE-listed healthcare stocks?

Which are the 10 biggest FTSE-listed healthcare stocks?

July 09, 2021 08:00 PM AEST| By Kamalika Ghosh

Summary The pandemic has made people more aware of the importance of research and development in pharmaceuticals, making Healthcare stocks the flavour of the season. AstraZeneca, Dechra Pharmaceuticals are some of the many healthcare stocks tha.....

 Tristel receives three product approvals in the US, Canada, and South Korea

Tristel receives three product approvals in the US, Canada, and South Korea

June 26, 2021 01:25 AM AEST| By Suhita Poddar

Summary Tristel received three regulatory approvals for its different categories of product. In the US, the company got approval for surface disinfectant from Environmental Protection Agency. The regulatory approvals will allow the company to .....

 More sales, more profits, but less dividends: Emma Walmsley’s roadmap for New GSK

More sales, more profits, but less dividends: Emma Walmsley’s roadmap for New GSK

June 24, 2021 02:25 AM AEST| By Kamalika Ghosh

GlaxoSmithKline’s (LON:GSK) CEO Emma Walmsley has said that by 2031, the company plans to make sales of over £33 billion and increase adjusted operating profit by 10 per cent in the next half-decade. However, the company plans to slash .....

 EU approves AstraZeneca Drug Koselugo for Treating NF1 in children

EU approves AstraZeneca Drug Koselugo for Treating NF1 in children

June 23, 2021 08:23 PM AEST| By Suhita Poddar

The European Union has approved the drug Koselugo, manufactured by AstraZeneca (LON: AZN) and Merck & Co, to treat children above 3 years of age with neurofibromatosis type 1 (NF1), a rare genetic disease. The drug was approved as per the SPRIN.....

AI on the Rise: A Look at Top AI Companies and Their Stocks

Send OTP Resend OTP in 30s

Recent Articles






Investing Tips

Previous Next